Navigation Links
Despite Sagging Economy, Viamedic Reports Solid Online Sales for Erectile Dysfunction Drugs
Date:12/25/2008

Cialis and Viagra Post Double-Digit Increases for 2008 .

Phoenix, AZ (PRWEB) December 25, 2008--Despite an increase in product cost and one of the worst economic downturns in history, erectile dysfunction (ED) prescription medications are paying huge dividends for online pharmacy Viamedic.com.

"The pattern of increased online sales for ED drugs is unmistakable for us," said Rich Bernstein, Marketing Director for Viamedic.com. "Not only are our current customers continuing to come back for reorders, but we also have a tremendous amount of new customers placing orders as well."

These numbers are right in line with those of the manufacturers of these products. Lilly states that Cialis revenue was up 21% for the third quarter of 2008, compared to the same quarter last year. Overall, revenues were up 24% through three quarters YTD, reaching $1.075 billion.

Pfizer declared that revenue for Viagra was up 13% both for the quarter and through three quarters of 2008, totaling $1.432 billion YTD.

Revenue for Levitra was flat, yet YTD revenues were up 5.5% with currency-adjusted change, and total sales were $248 million Euros through three quarters ($342.5 million U.S.).

Although many consider ED medications to be non-necessity items, men apparently think otherwise
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Coerced medication used in psychiatric care despite lack of clinical evidence
2. Jennie Finch Shares how to Fire up the Romance Despite the Demands of the Holidays
3. Hopes for AIDS Vaccine Still Alive Despite Setbacks
4. Despite Economy, Oregon Wine Benefit !Salud! Raises Over $735,000
5. Despite national guidelines, private insurers, ER, federal and state agencies fail to routinely test for HIV
6. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
7. Bone cancer treatment ineffective, despite promising laboratory data
8. Despite U.S. economy, more Americans seeking cosmetic surgery overseas
9. Despite Credit Crunch, Medisave Sees Strong Sales Increase in 2008
10. Stroller Strides(R) Franchises Succeed Despite Economic Climate
11. Satyam Posts 28 Percent Year-over-Year Revenue Growth in Second Quarter Despite Slowdown in Key Markets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , ANN ARBOR, Mich., Dec. 3 A...n healthcare reform legislation, but most lack con...lity of medical care will improve in the next year...Reuters. ,, Sixty percent of survey respondents...ded in final healthcare reform legislation. Only a...
(Date:12/2/2009)... , MINNEAPOLIS, Dec. 3 /PRNewswire-USNewswire/...ters (AAPCC) has designated Hennepin Regional Pois...ed poison control center - a major milestone for t...e Hennepin Regional Poison Center among 58 accredi...creditation represents a major accomplishment. It ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repo...report is available in its catalogue: ,, Kina....reportlinker.com/p0166819/Kinase-Inhibitors-Globa...arket, providing data for the years 2005 through 2...nnual growth rates (CAGRs) through 2014 ,, An ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repor...eport is available in its catalogue: ,, Antibi...l Markets ,, http://www.reportlinker.com/p016...gies-Global-Markets.html ,, Provide an in-dept...stance and antibiotics technologies ,, Offer an...
(Date:12/2/2009)... , BOSTON, Dec. 2 The...e traffic rises 8%. According to Coremetrics, a m... 13.7 percent on Cyber Monday compared to Cyber Mo...on,s Bella Sante Day Spas who reported today "Cy...ay Internet sales rose 59%" - said Tiffany Amorosi...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 2Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3
...in the presence of disinfecting solutions , ...ation is common in contact lens storage cases, say...en in two-thirds of 30 storage cases used by 16 pe... was the most common type of pathogen (41 percent)...
...today announced it has filed,an additional law sui...t,Genesis Pharmaceuticals (OTC Bulletin Board: GNP... (GTEC) and Genesis Equity Partners II (GEP II) fo...due under,the note. , GEP II borrowed $190,0...
...27, 2008 Suffering from end-stage renal disease ... hospitalier de l,Universit de Montral (CHUM), hav...akthrough: high efficacy hemodiafiltration (HDF). ..., preliminary results show a clear advantage of hi...
...ety of general vs. local delivery , , WEDN...rgery to treat carotid (neck) artery blockages are...nesthesia, according to a study by U.K. researcher...eries increase the risk of stroke, and a procedure...
... aged care nurses are considering quitting in the ...sity of Melbourne study. , The study, conducted b...University of Melbourne and the Australian Nursing...cites excessive workloads, cost cutting, a hostile...
...wswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.,(NYS... and medical device,research and development outso...ited States, today announced Edward Hu, the Compan...tandard Time. , (Photo: http://www.newscom....
Other Medicine News:Health News:Contact Lens Cases Often Contaminated 2Health News:China West II Files Suit Against Genesis Pharmaceuticals and Capital Research Group Inc, Announces Conference Call Details 2Health News:Major North American breakthrough for dialysis patients 2Health News:Major North American breakthrough for dialysis patients 3Health News:Anesthesia Type Won't Influence Neck Artery Surgery Outcomes 2Health News:Aged care workers to leave industry en masse due to stress, warns University of Melbourne study 2Health News:WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference 2
(Date:12/3/2009)..., , JERSUSALEM and NEEDHAM, Massachuse...Systems Ltd. (SIX Swiss Exchange: ORIDN) today ann...ocap(R) portable capnographs for its RTW (Rettungs...n help paramedic teams to assess the ventilation s... that affect respiratory status such as displaced ...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ -...earch report is available in its catalogue: ,, ...://www.reportlinker.com/p0164303/Arthroscopes---A-...ic procedures are on rise, owing to their mounting... ankles, elbow, wrists, and hips, apart from knees...
(Date:12/2/2009)..., , PALO ALTO, Calif., Dec. 2 /PRNewswir...unced that on November 25, 2009, Varian, Inc. file... its Annual Report on Form 10-K for the fiscal yea...e accessed through the Company,s web site at www.v...Filings," and then on "10-K" in the table shown. ...
Breaking Medicine Technology:Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Amerigroup Corporation to Present at the 18th Annual Credit Suisse Healthcare Conference on November 12 60613 1Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 1Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 2Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 3Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 4Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 5Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 6Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 7Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 8Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 9Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 10Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 11Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 12Tolera Therapeutics Files IND Application for TOL101 Appoints OToole to Lead Clinical Operations 14705 1Tolera Therapeutics Files IND Application for TOL101 Appoints OToole to Lead Clinical Operations 14705 2
Blade Holder
Reveal XVI
...k's ophthalmic Nd: YAG laser YC-1600 is a lightwei...versatility and clinical performance., ,Key Fe..., Lightweight Model ,Further weight reduction...in your office.,, Aiming Beam Rotation ,...
...eart of the innovative EUS EXERA system from Olymp...formance to meet all of your observation and diagn...nic gastrovideoscope, the EU-M60 allows for increa...the body and greater resolution allowing you to fo...
Medicine Products: